Dermatomyositis
There are 8 clinical trials
-
Comparing single drug (prednisone alone) with combination drug (prednisone + methotrexate) treatment in people with polymyositis or dermatomyositis
Location: Europe
Status: Recruiting -
Evaluating the long-term safety of sifalimumab in adults with myositis
Location: North America
Status: Recruiting -
Evaluating the safety of multi-dose MEDI-545 in adults with dermatomyositis or polymyositis
Location: North America
Status: Completed -
Investigating genes in patients with polymyositis, dermatomyositis and inclusion body myositis
Location: United Kingdom
Status: Recruiting -
Measuring the risk of coronary heart disease in patients with inflammatory muscle diseases
Location: United Kingdom
Status: Recruiting -
Rituximab for the treatment of dermatomyositis polymyositis
Location: Europe, North America
Status: Ongoing but is not recruiting patients -
Stem cell transplantation in myositis
Location: North America
Status: Recruiting -
Testing a new drug (BAF312) in patients with polymyositis and dermatomyositis
Location: Europe, North America
Status: Active but not recruiting
Page 1 of 1
